The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
about
The spectrum of disease in chronic traumatic encephalopathyEvidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathyThe synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementiaRegional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)rCBF SPECT for detection of frontotemporal dementia in people with suspected dementiaPlasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive declinePlasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaPlasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive declineCharacterizing CGI-94 (comparative gene identification-94) which is down-regulated in the hippocampus of early stage Alzheimer's disease brainFE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4Close association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brainsCharacterizing the new transcription regulator protein p60TRPFailure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patientsApolipoprotein E and Alzheimer diseaseOmega-3 fatty acids: potential role in the management of early Alzheimer's diseaseEvidence for an association between KIBRA and late-onset Alzheimer's diseasePGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementiaAn immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progressionAbeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's diseaseCharacterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadicsIn vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brainsRelationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studiesDown-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neuronsThe role of macrophage migration inhibitory factor in Alzheimer's diseaseElevated microsomal prostaglandin-E synthase-1 in Alzheimer's diseaseZinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluidVascular risk factors and dementia: how to move forward?Argyrophilic grains: a distinct disease or an additive pathology?Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed casesReduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's diseaseDementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's diseaseSoluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's diseaseInteraction of presenilins with the filamin family of actin-binding proteinsNAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant
P2860
Q22242925-4080782D-B407-465C-85F9-D7BAE6C7B2A9Q22251077-FE1386C7-F6E0-496F-A1D3-68FEEE6185A4Q22252705-5AF4FF5F-6D7B-4B15-BE8B-CB97F295F671Q24186916-FD41FB29-7DD9-46AB-B4E6-0AE3067F07D7Q24194742-AAA1FB50-6FCF-48C8-90F5-6A71758BA29EQ24200257-4BCBC18F-127A-4F92-8CD2-096599D97EA4Q24201039-16A1867C-B49F-4AFB-B734-0AFFBF83C703Q24202037-43221A15-5D51-4063-994B-BE6745F6F8A4Q24234762-670B604D-D6FC-4E6E-8DD4-AD758D5F293EQ24235058-006B6B02-0C99-4DBE-846A-BFF4073EF45FQ24236736-3A6E4AFF-5D4A-4ACD-A358-621A531F87CBQ24292350-8DE25A2C-4B00-4BEB-A429-5A1B3D822A64Q24312011-366A8339-9568-4166-859E-21AE563B6408Q24317142-F7CF08E8-1FE3-417C-BE79-E97077BAA175Q24318664-193AAFB1-B21A-4B2F-B01B-2DA187FB2ED9Q24551398-465E467A-8214-4288-A3CF-26778DF860D4Q24563061-AB11F0ED-7D4F-4698-A681-248AB62A432FQ24595490-C83FFF41-108D-4E4D-A414-38C06E90FC14Q24598464-8608CA09-D926-4A19-A242-211ACEAE75D9Q24604133-4801CD7C-F8AC-4B33-9D99-C9FFC30996C3Q24613146-7BB91E37-4239-4113-A5D1-9AD84145E500Q24620404-AFD582BC-017E-4ED2-894B-F038E799FD14Q24620476-CDB04851-B27B-4D06-A50B-F325BD6A97CAQ24630288-A997B479-E5A9-43AC-B7AA-62DC17973ED9Q24630362-F7D7558F-6E92-4A95-BA7D-44B9457CB5E0Q24630918-E69CD257-CD06-4788-99E5-C70686008A9FQ24632616-BA47A7CE-4945-4CFC-8E70-E223700DBB79Q24633831-8781105C-C4D7-43D0-A6EA-437A1CE35E95Q24633872-C1FF2C1C-EC1D-41D1-A633-B3FE646FE7B0Q24634765-3FB6BA94-0A1D-438B-85F1-089D9ED1350CQ24647957-4C28F584-96CD-4961-AB97-05C7F25FFB98Q24649556-25349FB4-9413-4907-ADDD-7E7971E6F0FDQ24650263-1E221D94-3442-49D6-8BA1-C200E4657E04Q24650928-9D984ECC-4619-41F2-BACE-17C91BD4C2E7Q24653609-A1F3DF69-09FE-40E1-8E1D-96DDB5E101E1Q24656640-31E86059-E2A2-4A02-82AB-66DDDF029156Q24657382-A04D0EDB-6469-42ED-8908-C9F2875C1F32Q24670696-C9CBAFB8-D21C-46EA-BD89-3A682D5D0287Q24674595-5D1F152C-2482-44F2-85E5-81FCD661A5D6Q24791908-EAE96100-48E3-4B50-A6BE-19BB9F7DE667
P2860
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The Consortium to Establish a ...... essment of Alzheimer's disease
@ast
The Consortium to Establish a ...... essment of Alzheimer's disease
@en
type
label
The Consortium to Establish a ...... essment of Alzheimer's disease
@ast
The Consortium to Establish a ...... essment of Alzheimer's disease
@en
prefLabel
The Consortium to Establish a ...... essment of Alzheimer's disease
@ast
The Consortium to Establish a ...... essment of Alzheimer's disease
@en
P2093
P3181
P356
P1433
P1476
The Consortium to Establish a ...... essment of Alzheimer's disease
@en
P2093
Brownlee LM
van Belle G
P304
P3181
P356
10.1212/WNL.41.4.479
P407
P577
1991-04-01T00:00:00Z